Voya Investment Management LLC Passage Bio, Inc. Transaction History

Voya Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.63 - $3.46 $23,662 - $50,228	-14,517 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$6.24 - $10.2 $2,034 - $3,325	-326 Reduced 2.2%	14,517 $92,000
Q2 2021 Aug 16, 2021	BUY	$12.44 - $19.45 $32,393 - $50,647	2,604 Added 21.28%	14,843 $197,000
Q1 2021 May 17, 2021	BUY	$16.24 - $29.83 $33,227 - $61,032	2,046 Added 20.07%	12,239 $214,000
Q4 2020 Feb 16, 2021	BUY	$14.28 - $29.73 $145,556 - $303,037	10,193 New	10,193 $261,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.